PHOENIX, Aug. 27,
2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ:
TRIN) ("Trinity"), a leading provider of diversified financial
solutions to growth-oriented companies, today announced the
commitment of $35 million in
equipment financing to ApiJect Systems, Corp ("ApiJect"), a
public-benefit medical technology company focused on prefilled,
single-dose injection devices.
Based in Stamford, CT, ApiJect
works with pharmaceutical companies to design rapidly scalable,
cost-efficient drug delivery systems, and then assists in
manufacturing those devices. ApiJect aims to enable more liquid
medicines and vaccines to effectively and safely reach more
patients across the world.
"We are proud to support ApiJect on their mission to make
injectable medicines and vaccines safer and accessible to
everyone," said Melana Ferguson,
Director, Equipment Finance at Trinity. "We look forward to working
with their talented leadership team to accelerate the company's
growth."
The new facility from Trinity will allow ApiJect to maximize the
value of their hard assets to continue to scale operations and fund
growth initiatives.
"We built the ApiJect injection platform to deliver an
affordable prefilled option for most, if not all, injection
medicines supported by a high volume manufacturing process and
compact supply chain," said Jay
Walker, Co-Founder, Executive Chairman, and CEO of ApiJect.
"With Trinity's partnership, we are well positioned to expand our
manufacturing capacity here in the U.S., file for regulatory
approval for our initial device in the coming months, and partner
with a growing list of pharma companies that want to use our
injection technology with their drugs." Mr. Walker concluded.
About Trinity Capital Inc.
Trinity Capital Inc. (Nasdaq: TRIN), an internally managed
business development company, is a leading provider of diversified
financial solutions to growth-stage companies with institutional
equity investors. Trinity Capital's investment objective
is to generate current income and, to a lesser extent, capital
appreciation through investments, including term loans and
equipment financings and equity-related investments. Trinity
Capital believes it is one of only a select group of specialty
lenders that has the depth of knowledge, experience and track
record in lending to growth stage companies. For more information,
please visit the Company's website at www.trinitycap.com.
About ApiJect Systems
ApiJect Systems, Corp. is a public-benefit medical technology
company working to bring prefilled, single-dose injections to more
people in every market. The ApiJect Platform enables pharmaceutical
and biotech companies to design scalable prefilled injectors and
efficiently fill-finish them with their injectable drug products.
This can be done either on one of their own ApiJect-licensed
Blow-Fill-Seal packaging lines or at one of our world-class
manufacturing partners.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/trinity-capital-inc-commits-35-million-in-equipment-financing-to-apiject-302230972.html
SOURCE Trinity Capital Inc.